AgomAb Therapeutics NV American Depositary Shares Strategic Asset Allocation Index

Latest as of December 2025: 0.0%

AgomAb Therapeutics NV American Depositary Shares strategic asset allocation index. AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $11.00K) total $11.00K, measured against net assets of $130.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See AGMB equity financing ratio to measure how much of total assets are equity-financed.

SAAI

0.0%
Strategic Assets / Net Assets

Strategic Assets

$11.00K
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$130.90 Million
USD

Strategic Asset Allocation Index of AgomAb Therapeutics NV American Depositary Shares (2021–2025)

Strategic asset allocation index of AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025. This chart shows how AgomAb Therapeutics NV American Depositary Shares's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $11.00K against net assets of $130.90 Million USD. Check AgomAb Therapeutics NV American Deposita tangible net worth ratio to evaluate the tangible quality of the company's equity base.

AgomAb Therapeutics NV American Depositary Shares Strategic Asset Allocation Index by Year (2021–2025)

AgomAb Therapeutics NV American Depositary Shares strategic asset allocation index by year from 2021 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AgomAb Therapeutics NV American Deposita (AGMB) market capitalisation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 0.0% $11.00K $- $11.00K $130.90 Million ▲ +0.0 pp
2024 0.0% $12.00K $- $12.00K $188.08 Million ▼ 0.0 pp
2023 0.0% $14.00K $- $14.00K $151.44 Million ▼ 0.0 pp
2022 0.0% $14.00K $- $14.00K $66.25 Million ▼ -0.3 pp
2021 0.3% $147.00K $- $147.00K $42.36 Million —
pp = percentage points